Bespoke Extracts (BSPK) Short-term Investments (2022)

Bespoke Extracts (BSPK) reported Short-term Investments of $12000.0 for Q3 2022, little changed sequentially from $12000.0 in Q2 2022.

Bespoke Extracts (BSPK) Short-term Investments (2022) Analysis & Trends

Bespoke Extracts (BSPK) has 1 years of Short-term Investments data on file, last reported at $12000.0 in Q3 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Haleon	87.22 Bn	85.35 Bn	-
2	Teva Pharmaceutical Industries	39.60 Bn	35.87 Bn	1.97 Bn
3	Zoetis	31.46 Bn	29.52 Bn	1.62 Bn
4	Takeda Pharmaceutical	26.49 Bn	22.44 Bn	4.39 Bn
5	United Therapeutics	23.03 Bn	20.88 Bn	648.10 Mn
6	Universe Pharmaceuticals	23.03 Bn	-10.56 Bn	-
7	Viatris	20.90 Bn	19.09 Bn	1.16 Bn
8	Neurocrine Biosciences	17.50 Bn	16.19 Bn	800.70 Mn
9	Elanco Animal Health	12.33 Bn	11.91 Bn	785.00 Mn
10	Bespoke Extracts	1.12 Mn	1.11 Mn	234,175.00

Download Data